Live Torrent Pharmaceuticals Share Price Chart

O 2610

H 2610

L 2610

VOL 98

Torrent Pharmaceuticals Performance

Days Range

Low: ₹2,583.95
High: ₹2,645.55
Previous Close ₹2,591.90
Open ₹2,610.00
Volume 2,85,999
Day’s Range ₹2,583.95 - ₹2,645.55
52W Range ₹1,598.45 - ₹2,744.00
Market Cap ₹87,677 Cr

Torrent Pharmaceuticals Fundamentals

ROCE (TTM) 20.93
P/E Ratio (TTM) 58.69
P/B Ratio 13.07
Industry P/E 35.69
Debt to Equity 0.67
ROE 20.02
EPS (TTM) 42.32
Dividend Yield 0.85
Book Value 198.19
Face Value 5

Torrent Pharmaceuticals Financials

Mar 2023Jun 2023Sep 2023Dec 2023
Net Sales2,4912,5912,6602,732
Expenses1,9601,9912,0362,076
Profit before tax433531559631
Operating Profit287378386443
Net Profit287378386443
EPS in Rs8.4811.1811.3910.5

About Torrent Pharmaceuticals

History of Torrent Pharmaceuticals Limited

Incorporated in 1972, Torrent Pharmaceuticals Limited is one of the leading pharma companies in India. It is a flagship company of the Torrent Group. The company is listed among the leaders in the therapeutic segment of Central Nervous System (CNS), Cardiovascular (CV), Vitamins Minerals Nutrients (VMN), Gastrointestinal (GI),  Anti-diabetes (AD), Gynaecology, Dermatology and Pain. 

In 1980, the company set up their first manufacturing facility in Ahmedabad. In May 1994, the company released its IPO. Torrent Pharmaceuticals Ltd started expanding its business, and in 1998, it acquired Pharma-related investments and the business of Torrent Exports Limited. 

Since its inception, the company acquired several companies, including Heumann Pharma from Pfizer, Elder Pharmaceuticals Limited’s India and Nepal Business, Zyg Pharma Private Limited, Unichem’s India and Nepal Business, Novartis Women Healthcare Brands and Curatio Health Care (I) Private Limited, which helped in strengthening the company’s position in the Indian Pharma market.  

The company has a presence in 40 countries in the world, including India, the USA, Brazil, Germany, etc. They have 7 manufacturing facilities in India and 1 Research and Development Facility in Gujarat. As of March 2023, the company had 644 approved patents for new API and formulation techniques for different geographies. They have more than 600 medical representatives and over 9,000 distributors. 

Business Segments of Torrent Pharmaceuticals Limited 

The company has a presence in different segments as follows:

  • Therapeutic Segments: Under this segment, the company offers various pharmaceutical products for a wide range of areas, including Cardiovascular, Diabetology, Gastrointestinal, Pain Management and Anti-Infective. Some of the brands under this segment include Orlica 60, Nikoran, Lopamide, Ahaglow S Facewash, etc.
  • Other Segments: The company also offers products for other treatments, such as Oncology, Nephrology, Pulmonology, Pediatric and Gynecology. The brands include Herwont Kit, Lymphtor, etc. 

As of March 31, 2023, there are 16 subsidiary companies under Torrent Pharmaceuticals Limited, including:

  • Zao Torrent Pharma: This is a wholly-owned subsidiary of the company that is involved in the distribution of prescription drugs.   
  • Torrent Pharma Inc: This wholly-owned subsidiary of Torrent Pharmaceuticals Limited that takes care of the company’s operations in the USA. 
  • Heunet Pharma GmbH: This wholly-owned subsidiary of Torrent Pharmaceuticals Limited that markets and sells pharma products in Germany.  

Key Personalities of Torrent Pharmaceuticals Limited

Samir Mehta, Chairman

Samir Mehta is the Chairman of the Torrent Group. Under his guidance, Torrent Pharmaceuticals Limited was established as one of the leading and fast-growing pharma companies in India. He helped the company take several strategic initiatives and expand into new therapies and regions.    

Aman Mehta, Director

Aman Mehta has been the Director of Torrent Pharmaceuticals Limited since August 2022. He has been part of several important integrations of the company and also market expansions and product launches. He is also the Director on the Board of Torrent Investments Private Limited, which is a holding company of the Torrent Group. 

Corporate Actions of Torrent Pharmaceuticals Limited

There are no records found on bonus shares, or stock splits from Torrent Pharmaceuticals Limited.

Parent Organisation Torrent
Founded 1972
Managing Director Sudhir Mehta
NSE Symbol TORNTPHARM

Peer Comparison

Stocks Market Cap (cr) Market Price (₹) 52 Week Low-High (₹)
Mankind Pharma Ltd ₹93,651.57

2393.05

52.65 (2.25%)

2355 - 2490View Peer Comparison
Cipla Ltd ₹109,341.46

1346.7

8.15 (-0.60%)

1344.5 - 1369.75View Peer Comparison
Zydus Lifesciences Ltd ₹96,543.12

959.45

0.25 (-0.03%)

944.6 - 968.05View Peer Comparison
Sun Pharmaceuticals Industries Ltd ₹369,401.61

1484.65

55.45 (-3.60%)

1477.7 - 1562.45View Peer Comparison
Divis Laboratories Ltd ₹99,176.41

3768.65

31.15 (0.83%)

3730 - 3780.05View Peer Comparison

What's Trending

Torrent Pharmaceuticals FAQs

What is the Share price of Torrent Pharmaceuticals (TORNTPHARM)?

Torrent Pharmaceuticals (TORNTPHARM) share price as of April 23, 2024, on NSE is Rs 2,638.00 (NSE) and Rs 2,633.15 (BSE) on BSE.

Can I buy Torrent Pharmaceuticals (TORNTPHARM) shares?

Yes, You can buy Torrent Pharmaceuticals (TORNTPHARM) shares by opening a Demat account with Angel One.

How do I buy Torrent Pharmaceuticals (TORNTPHARM) from Angel One?

Torrent Pharmaceuticals (TORNTPHARM) share can be brought through the following modes:
  1. Direct investment: You can buy Torrent Pharmaceuticals (TORNTPHARM) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Torrent Pharmaceuticals (TORNTPHARM) shares.

What is the total Asset of Torrent Pharma?

The total asset of Torrent Pharma is Rs. 12,906 crores.

What is the main business of Torrent Pharma?

The main business of Torrent Pharma is focused on conducting research and development along with manufacturing and marketing of generic formulations of pharmaceuticals. Its emphasis is on the therapeutic areas of the cardiovascular and central nervous systems.

Who are the promoters of Torrent Pharma?

The primary promoter of Torrent Pharma is Torrent Investments Private Limited.

What are the Subsidiaries that comes under Torrent Pharma?

Some of the subsidiaries that come under Torrent Pharma are Zao Torrent Pharma, Torrent Do Brasil Ltda., Torrent Pharma GmbH, Heumann Pharma GmbH & Co. Generica KG, Heunet Pharma GmbH, Torrent Pharma Inc., Torrent Pharma Philippines Inc., and Laboratorios Torrent, S.A. de C.V.